These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
|
|
Preliminary Proxy Statement
|
|
o
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
ý
|
|
Definitive Proxy Statement
|
|
o
|
|
Definitive Additional Materials
|
|
o
|
|
Soliciting Material Pursuant to §240.14a-12
|
|
x
|
|
No fee required.
|
|
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
5)
|
Total fee paid:
|
|
o
|
|
Fee paid previously with preliminary materials.
|
|
o
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
1)
|
Amount Previously Paid:
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
|
3)
|
Filing Party:
|
|
|
4)
|
Date Filed:
|
|
Dan Rosensweig
President and Chief Executive Officer
|
|
Dave Borders Jr.
General Counsel and Secretary
|
|
|
|
|
|
•
|
vote in person – we will provide a ballot to stockholders who attend the meeting and wish to vote in person;
|
|
•
|
vote via telephone or Internet – in order to do so, please follow the instructions shown on your Notice of Internet Availability or proxy card; or
|
|
•
|
vote by mail – if you request or receive a paper proxy card and voting instructions by mail, simply complete,
|
|
•
|
delivering to the Corporate Secretary of Chegg (by any means, including facsimile) a written notice stating that the proxy is revoked;
|
|
•
|
signing and delivering a proxy bearing a later date;
|
|
•
|
voting again by telephone or via the Internet; or
|
|
•
|
attending and voting at the meeting (although attendance at the meeting will not, by itself, revoke a proxy).
|
|
•
|
view our proxy materials for the meeting via the Internet; and
|
|
•
|
instruct us to send our future proxy materials to you electronically by email.
|
|
•
|
selects a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;
|
|
•
|
reviews the continuing independence and performance of and oversees our company’s relationship with the independent registered public accounting firm;
|
|
•
|
discusses the scope, audit planning, and staffing of the independent registered public accounting firm;
|
|
•
|
discusses the results of the audit with the independent registered public accounting firm, and reviews, with management and the independent registered public accounting firm, our interim and year-end operating results;
|
|
•
|
develops procedures for employees to submit concerns anonymously about questionable accounting or auditing matters;
|
|
•
|
considers and reviews the adequacy of our internal accounting controls and audit procedures;
|
|
•
|
oversees the activities of the internal audit function within the company; and
|
|
•
|
approves or, as required, pre-approves all audit and non-audit services not prohibited by law to be performed by the independent registered public accounting firm.
|
|
•
|
reviews and determines the compensation of our executive officers and recommends to our board of directors the compensation for our directors;
|
|
•
|
administers our stock and equity incentive plans;
|
|
•
|
reviews and approves and makes recommendations to our board of directors regarding incentive compensation equity-based grants and equity plans; and
|
|
•
|
establishes and reviews our company’s overall compensation strategy.
|
|
•
|
identifies, recruits, evaluates and recommends nominees to our board of directors and committees of our board of directors;
|
|
•
|
conducts searches for qualified directors;
|
|
•
|
annually evaluates the performance of our board of directors and of individual directors;
|
|
•
|
considers and makes recommendations to the board of directors regarding the composition and leadership structure of the board of directors and its committees;
|
|
•
|
reviews developments in corporate governance practices;
|
|
•
|
evaluates the adequacy of our corporate governance practices and reporting; and
|
|
•
|
makes recommendations to our board of directors concerning corporate governance matters.
|
|
Name of Director/Nominee
|
Age
|
Principal Occupation
|
Director Since
|
|
John York
(1)
|
38
|
Chief Executive Officer of the San Francisco 49ers
|
June 2013
|
|
(1)
|
Member of the compensation committee and nominating and corporate governance committee. Mr. York's resignation from the audit committee was accepted in December 2018 and Mr. York was concurrently appointed as chair of the compensation committee.
|
|
Name of Director
|
Age
|
Principal Occupation
|
Director Since
|
|
Class I Directors -
Terms Expiring 2020:
|
|
|
|
|
Reneé Budig
(1)
|
58
|
Executive Vice President and Chief Financial Officer, CBS Interactive (a division of CBS Corporation)
|
November 2015
|
|
Dan Rosensweig
(2)
|
57
|
President, Chief Executive Officer and Co-Chairperson
|
March 2010
|
|
Ted Schlein
(1)(3)(4)
|
55
|
General Partner of Kleiner Perkins
|
December 2008
|
|
|
|
|
|
|
Class II Directors -
Terms Expiring 2021:
|
|
|
|
|
Marne Levine
(3)(5)
|
48
|
Vice President, Global Partnerships and Business Development of Facebook, Inc.
|
May 2013
|
|
Richard Sarnoff
(1)(2)
|
60
|
Chairman of Media, Entertainment, and Education Investing of Kohlberg Kravis Roberts & Co., and Co-Chairperson
|
August 2012
|
|
(1)
|
Member of the audit committee.
|
|
(2)
|
Co-chairperson of our board of directors.
|
|
(3)
|
Member of the nominating and corporate governance committee.
|
|
(4)
|
Mr. Schlein's resignation from the compensation committee was accepted in December 2018 and Mr. Schlein was concurrently appointed to the audit committee.
|
|
(5)
|
Member of the compensation committee.
|
|
•
|
an annual cash retainer for serving on our board of directors of $40,000;
|
|
•
|
an annual cash retainer for serving in a non-chair position on the audit committee of $10,000, on the compensation committee of $10,000 and on the nominating and corporate governance committee of $5,000; and
|
|
•
|
an annual cash retainer for serving as the chair of the audit committee of $20,000, for serving as the chair of the compensation committee of $20,000 and for serving as the chair of the nominating and corporate governance committee of $10,000.
|
|
Name
|
|
Fees Earned
or Paid in Cash
($)
|
|
All Other Compensation ($)
|
|
RSU Awards
($)
(3)
|
|
Option
Awards
($)
(3)
|
|
Total
($)
|
|
Reneé Budig
|
|
60,000
|
|
|
|
174,986
|
|
—
|
|
234,986
|
|
Jeffrey Housenbold
(1)
|
|
50,000
|
|
|
|
174,986
|
|
—
|
|
224,986
|
|
Marne Levine
|
|
60,000
|
|
|
|
174,986
|
|
—
|
|
234,986
|
|
Richard Sarnoff
|
|
50,000
|
|
$7,612
(2)
|
|
254,960
|
|
—
|
|
312,572
|
|
Ted Schlein
|
|
65,000
|
|
|
|
174,986
|
|
—
|
|
239,986
|
|
John York
|
|
55,000
|
|
|
|
174,986
|
|
—
|
|
229,986
|
|
(1)
|
Mr. Housenbold resigned from the board of directors effective April 11, 2019.
|
|
(2)
|
Represents reimbursements to Mr. Sarnoff for travel expenses incurred to attend board meetings during the year ended December 31, 2018.
|
|
(3)
|
Amounts shown in this column do not reflect dollar amounts actually received by non-employee directors. Instead these amounts reflect the aggregate grant date fair value calculated in accordance with Financial Accounting Standards Board, Accounting Standards Codification Topic 718, Compensation-Stock Compensation, (formerly SFAS 123R) (“ASC 718”), for awards granted during 2018. During 2018, each non-employee member of the board of directors who was a director after the close of our annual meeting of stockholders on June 7, 2018 was granted a restricted stock unit (“RSU”) award covering 6,214 shares of our common stock. For purposes of determining the number of shares of common stock subject to the RSU award, an aggregate grant date fair value of $175,000 was used. In conjunction with his appointment as non-executive Co-Chairperson of the Board, Richard Sarnoff received an additional RSU award covering 2,574 shares of our common stock and for purposes of determining the number of shares of common stock subject to this additional RSU award, an aggregate grant date fair value of $80,000 was used. The grant date fair value for RSU awards was determined using the closing share price of our common stock on the date of grant. For information on other valuation assumptions with respect to stock awards, refer to note 13 of the notes to consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018. There can be no assurance that this grant date fair value will ever be realized by the non-employee director.
|
|
|
|
|
|
|
Name
|
Option
Awards
|
|
RSU Awards
|
|
Reneé Budig
|
88,445
|
|
6,214
|
|
Jeffrey Housenbold
(1)
|
76,917
|
|
6,214
|
|
Marne Levine
|
175,092
|
|
6,214
|
|
Richard Sarnoff
|
243,586
|
|
8,788
|
|
Ted Schlein
|
—
|
|
6,214
|
|
John York
|
178,956
|
|
6,214
|
|
(1)
|
Mr. Housenbold resigned from the board of directors effective April 11, 2019. The 6,214 unvested RSUs vested immediately prior to the acceptance of his resignation from the board of directors.
|
|
•
|
Attract, motivate and retain highly-qualified executive officers in a competitive market;
|
|
•
|
Provide compensation to our executives that are competitive and reward the achievement of challenging business objectives; and
|
|
•
|
Align our executive officers’ interests with those of our stockholders by providing a significant portion of total compensation in the form of equity awards.
|
|
Fees Billed to Chegg
|
|
Fiscal Year 2018
|
||
|
Audit fees
|
|
$
|
2,000,159
|
|
|
Audit related fees
|
|
—
|
|
|
|
Tax fees
|
|
35,490
|
|
|
|
All other fees
|
|
—
|
|
|
|
Total fees
|
|
$
|
2,035,649
|
|
|
Fees Billed to Chegg
|
|
Fiscal Year 2017
|
||
|
Audit fees
|
|
$
|
3,155,177
|
|
|
Audit related fees
|
|
—
|
|
|
|
Tax fees
|
|
15,000
|
|
|
|
All other fees
|
|
—
|
|
|
|
Total fees
|
|
$
|
3,170,177
|
|
|
•
|
each stockholder known by us to be the beneficial owner of more than 5% of our common stock;
|
|
•
|
each of our directors or director nominee;
|
|
•
|
each of our named executive officers; and
|
|
•
|
all of our directors and executive officers as a group.
|
|
Name of Beneficial Owner
|
|
Number of Shares Beneficially Owned
|
|
Percentage
Owned
|
|
Named Executive Officers and Directors:
|
|
|
|
|
|
Dan Rosensweig
(1)
|
|
3,251,934
|
|
2.7%
|
|
Andrew Brown
(2)
|
|
428,401
|
|
*
|
|
Nathan Schultz
(3)
|
|
484,575
|
|
*
|
|
Michael Osier
(4)
|
|
378,536
|
|
*
|
|
Esther Lem
(5)
|
|
532,142
|
|
*
|
|
Jenny Brandemuehl
(6)
|
|
243,255
|
|
*
|
|
Renee Budig
(7)
|
|
61,639
|
|
*
|
|
Jeffrey Housenbold
(8)
|
|
95,111
|
|
*
|
|
Marne Levine
(9)
|
|
212,893
|
|
*
|
|
Richard Sarnoff
(10)
|
|
251,781
|
|
*
|
|
Ted Schlein
(11)
|
|
223,540
|
|
*
|
|
John York
(12)
|
|
174,670
|
|
*
|
|
All executive officers and directors as a group (15 persons)
(13)
|
|
6,858,456
|
|
5.8%
|
|
5% Stockholders:
|
|
|
|
|
|
Baillie Gifford & Co
(14)
|
|
11,677,668
|
|
9.9%
|
|
BlackRock, Inc., as nominee
(15)
|
|
7,388,588
|
|
6.2%
|
|
PRIMECAP Mgmt Co
(16)
|
|
8,427,690
|
|
7.1%
|
|
Sylebra HK Company Limited
(17)
|
|
6,946,262
|
|
5.9%
|
|
The Vanguard Group, Inc.
(18)
|
|
11,736,192
|
|
9.9%
|
|
*
|
Represents beneficial ownership of less than 1% of our outstanding shares of common stock.
|
|
(1)
|
Consists of (a) 1,527,417 shares held by Mr. Rosensweig, (b) 69,346 shares held by Daniel L and Linda Rosensweig, Co-Trustees of the Rosensweig Family Revocable Trust U/A/D03-12-07, (c) 53,251 shares subject to nonqualified options transferred to Daniel Lee Rosensweig and Linda Rosensweig Co-Trustees of the Rosensweig 2012 Irrevocable Children’s Trust u/a/d 11/6/2012 on November 8, 2013, but reported under Mr. Rosensweig’s name for financial reporting purposes, and (d) 1,601,920 shares subject to stock options held by Mr. Rosensweig that are exercisable within 60 days of April 8, 2019.
|
|
(2)
|
Consists of (a) 88 shares held by Mr. Brown, (b) 84,559 shares held by The Andy and Pam Brown Family Trust, of which Mr. Brown is a Co-Trustee, and (c) 343,754 shares subject to stock options held by Mr. Brown that are exercisable within 60 days of April 8, 2019.
|
|
(3)
|
Consists of (a) 182,512 shares held by Mr. Schultz, and (b) 302,063 shares subject to stock options held by Mr. Schultz that are exercisable within 60 days of April 8, 2019.
|
|
(4)
|
Consists of 378,536 shares held by Mr. Osier.
|
|
(5)
|
Consists of (a) 242,515 shares held by Ms. Lem, and (b) 289,627 shares subject to stock options held by Ms. Lem that are exercisable within 60 days of April 8, 2019.
|
|
(6)
|
Consists of (a) 127,094 shares held by Ms. Brandemuehl, (b) 58,578 shares held by Jenny and Mark Brandemuehl, Co-Trustees of the Brandemuehl Family Trust U/A/D 01-05-04, and (c) 57,583 shares subject to stock options held by Ms. Brandemuehl that are exercisable within 60 days of April 8, 2019.
|
|
(7)
|
Consists of (a) 11,980 shares held by Ms. Budig and, (b) 43,445 shares subject to stock options held by Ms. Budig that are exercisable within 60 days of April 8, 2019, and (c) 6,214 RSUs which are subject to vesting conditions expected to occur within 60 days of April 8, 2019.
|
|
(8)
|
Consists of (a) 11,980 shares held by Mr. Housenbold and, (b) 76,917 shares subject to stock options held by Mr. Housenbold that are exercisable within 60 days of April 8, 2019, and (c) 6,214 RSUs which are subject to vesting conditions expected to occur within 60 days of April 8, 2019. Mr. Housenbold resigned from the board of directors effective April 11, 2019.
|
|
(9)
|
Consists of (a) 31,587 shares held by Ms. Levine and, (b) 175,092 shares subject to stock options held by Ms. Levine that are exercisable within 60 days of April 8, 2019, and (c) 6,214 RSUs which are subject to vesting conditions expected to occur within 60 days of April 8, 2019.
|
|
(10)
|
Consists of (a) 41,980 shares held by Mr. Sarnoff and, (b) 203,587 shares subject to stock options held by Mr. Sarnoff that are exercisable within 60 days of April 8, 2019, and (c) 6,214 RSUs which are subject to vesting conditions expected to occur within 60 days of April 8, 2019.
|
|
(11)
|
Consists of (a) 172,326 shares held by Mr. Schlein, (b) 45,000 shares held by the Schlein Family Trust Dtd 4/20/99, and (c) 6,214 RSUs which are subject to vesting conditions expected to occur within 60 days of April 8, 2019.
|
|
(12)
|
Consists of (a) 2,000 shares held by Mr. York and, (b) 166,456 shares subject to stock options held by Mr. York that are exercisable within 60 days of April 8, 2019, and (c) 6,214 RSUs which are subject to vesting conditions expected to occur within 60 days of April 8, 2019.
|
|
(13)
|
Consists of (a) 3,510,986 shares, (b) 3,310,186 shares subject to stock options that are exercisable within 60 days of April 8, 2019, and (c) 37,284 RSUs which are subject to vesting conditions expected to occur within 60 days of April 8, 2019, each of which are held by our directors and officers as a group.
|
|
(14)
|
Consists of 11,677,668 shares held by Baillie Gifford & Co. The principal business address for all entities affiliated with Baillie Gifford & Co is Calton Square, 1 Greenside Row, Edinburgh, EH1 3AN, Scotland, UK. Securities reported as being beneficially owned by Baillie Gifford & Co. are held by Baillie Gifford & Co. and/or one or more of its investment adviser subsidiaries, which may include Baillie Gifford Overseas Limited, on behalf of investment advisory clients, which may include investment companies registered under the Investment Company Act, employee benefit plans, pension funds or other institutional clients.
|
|
(15)
|
Consists of 7,388,588 shares held by BlackRock, Inc. The principal business address for all entities affiliated with BlackRock, Inc. is 55 East 52nd Street, New York, New York 10055.
|
|
(16)
|
Consists of 8,427,690 shares held by PRIMECAP Management Company. The principal business address for all entities affiliated with PRIMECAP Management Company is 177 E. Colorado Blvd., 11th Floor, Pasadena, California 91105.
|
|
(17)
|
Consists of 6,946,262 shares owned by Sylebra Capital Management. Sylebra HK may be deemed to beneficially own the Shares by virtue of its position as the investment advisor to Sylebra Cayman in relation to Sylebra Capital Partners Master Fund, Ltd and other advisory clients. Sylebra Cayman serves as the investment manager to Sylebra Capital Partners Master Fund, Ltd and is the parent of Sylebra HK. Mr. Gibson owns 100% of the shares of Sylebra HK and Sylebra Cayman. In such capacities, Sylebra HK, Sylebra Cayman, and Mr. Gibson may be deemed to share voting and dispositive power over the Shares held for the Sylebra Capital Partners Master Fund Ltd and other advisory clients. The principal business address for all entitites affiliated with Sylebra HK Company Limited is 28 Hennessy Road, 20th Floor, Wan Chai, Hong Kong (SAR).
|
|
(18)
|
Consists of 11,494,350 shares held by The Vanguard Group, Inc. Vanguard Fiduciary Trust Company (“VFTC”), a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 212,792 shares or .18% of the Common Stock outstanding of the Company as a result of its serving as investment manager of collective trust accounts. Vanguard Investments Australia, Ltd. (“VIA”), a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 29,050 shares or .02% of the Common Stock outstanding of the Company as a result of its serving as investment manager of Australian investment offerings. The principal business address for all entities affiliated with The Vanguard Group, Inc. is 100 Vanguard Blvd., Malvern, Pennsylvania 19355.
|
|
Name
|
|
Age
|
|
Position(s)
|
|
Dan Rosensweig
|
|
57
|
|
President, Chief Executive Officer and Co-Chairperson
|
|
Dave Borders Jr.
|
|
45
|
|
General Counsel
|
|
Jenny Brandemuehl
|
|
55
|
|
Chief People Officer
|
|
Andrew Brown
|
|
59
|
|
Chief Financial Officer
|
|
John Fillmore
|
|
39
|
|
Chief Business Officer
|
|
Esther Lem
|
|
63
|
|
Chief Marketing Officer
|
|
Michael Osier
|
|
56
|
|
Chief Information Officer and Chief Outcomes Officer
|
|
Nathan Schultz
|
|
41
|
|
President of Learning Services
|
|
Name
|
Title
|
|
Dan Rosensweig
(1)
|
President, Chief Executive Officer and Co-Chairperson
|
|
Andrew Brown
|
Chief Financial Officer
|
|
Nathan Schultz
(2)
|
President of Learning Services
|
|
Michael Osier
(3)
|
Chief Information Officer and Chief Outcomes Officer
|
|
Esther Lem
|
Chief Marketing Officer
|
|
Jenny Brandemuehl
|
Chief People Officer
|
|
(1)
|
Mr. Rosensweig transitioned from the sole Chairperson to Co-Chairperson concurrent with the appointment of Richard Sarnoff as Co-Chairperson on July 2018.
|
|
(2)
|
Mr. Schultz was promoted from Chief Learning Officer to President of Learning Services on December 20, 2018.
|
|
(3)
|
Mr. Osier became Chief Information Officer on December 20, 2018 in addition to his role as Chief Outcomes Officer.
|
|
What We Do
|
What We Don't Do
|
|
Maintain a compensation committee comprised solely of independent directors
|
Provide defined benefit or contribution retirement plans or arrangements, other than our Section 401(k) plan which is generally available to all employees
|
|
Use an independent compensation consultant
|
Provide excise tax gross-ups on change of control severance payments
|
|
Use a representative and relevant peer group for assessing compensation
|
Provide excessive benefits and/or perquisites to our executive officers, including post-termination benefits
|
|
Consider stockholder dilution and burn rate in our equity compensation decisions
|
Include “single-trigger” vesting change of control provisions in equity awards
|
|
Prioritize stockholder alignment with a high percent of pay mix allocated to equity compensation, half of which is performance-conditioned
|
Allow hedging or monetization transactions, such as zero cost collars and forward sale transactions
|
|
Set a maximum payout on performance-based equity incentive awards at 150% of target
|
Provide dividends or credits on unvested incentive equity awards
|
|
Maintain a recoupment policy on cash or equity incentive awards in the event of a financial restatement
|
|
|
Maintain stock ownership guidelines for our executive officers and non-employee directors
|
|
|
Ongoing stockholder outreach
|
|
|
Annual Say-On-Pay Vote
|
|
|
•
|
Attract, motivate and retain highly-qualified executive officers in a competitive market;
|
|
•
|
Reward the achievement of challenging business objectives; and
|
|
•
|
Align our executive officers’ interests with those of our stockholders by providing a significant portion of total compensation in the form of equity awards.
|
|
•
|
GICS Industrie
s: Internet & Catalog Retail and Internet Software & Services
|
|
•
|
Financial Size
: Approximately one-third to three times our total revenues and one-third to three times our market capitalization value
|
|
2U
|
LogMeIn
|
Stamps.com
|
|
Blucora
|
Mulesoft*
|
TrueCar
|
|
Box
|
New Relic
|
Twilio
|
|
Cornerstone OnDemand
|
Nutanix
|
XO Group*
|
|
Coupa Software
|
Pandora Media*
|
Yelp
|
|
Instructure
|
Quotient Technology
|
|
|
LivePerson
|
Shutterstock
|
|
|
Named Executive Officer
|
Fiscal Year 2017
|
Fiscal Year 2018
(1)
|
Change
|
|
Dan Rosensweig
|
$920,000
|
$1,000,000
|
8.7%
|
|
Andrew Brown
|
$520,000
|
$600,000
|
15.4%
|
|
Nathan Schultz
|
$450,000
|
$500,000
|
11.1%
|
|
Michael Osier
|
$450,000
|
$500,000
|
11.1%
|
|
Esther Lem
|
$390,000
|
$400,000
|
2.6%
|
|
Jenny Brandemuehl
|
$390,000
|
$400,000
|
2.6%
|
|
(1)
|
Effective as of March 1, 2018.
|
|
Performance Level
|
Threshold
|
Target
|
Maximum
|
|
Payout % of Award
|
50%
|
100%
|
150%
|
|
Chegg Services Revenue
|
$230,000,000
|
$240,000,000
|
$250,000,000
|
|
Adjusted EBITDA*
|
$68,000,000
|
$74,000,000
|
$85,000,000
|
|
|
Number of Shares Granted
|
|
Grant Date Fair Value of Awards
|
|
||
|
Named Executive Officer
|
Time-Vesting RSUs
|
PSUs
(Target)*
|
PSUs (Maximum)
|
Time-Vesting RSUs
|
PSUs
(Target)*
|
PSUs (Maximum)
|
|
Dan Rosensweig
|
164,974
|
164,974
|
247,461
|
$3,249,988
|
$3,249,988
|
$4,874,982
|
|
Andrew Brown
|
65,989
|
65,989
|
98,984
|
$1,299,983
|
$1,299,983
|
$1,949,985
|
|
Nathan Schultz
|
53,299
|
53,299
|
79,949
|
$1,049,990
|
$1,049,990
|
$1,574,995
|
|
Michael Osier
|
53,299
|
53,299
|
79,949
|
$1,049,990
|
$1,049,990
|
$1,574,995
|
|
Esther Lem
|
43,147
|
43,147
|
64,720
|
$849,996
|
$849,996
|
$1,274,984
|
|
Jenny Brandemuehl
|
43,147
|
43,147
|
64,720
|
$849,996
|
$849,996
|
$1,274,984
|
|
|
|
Number of PSUs Earned
|
|
|
Named Executive Officer
|
Chegg Services Revenues (150.0% of Target)
|
Adjusted EBITDA (142.1% of Target)
|
Total Number of PSUs Earned (146.1% of Target)
|
|
Dan Rosensweig
|
123,732
|
117,231
|
240,963
|
|
Andrew Brown
|
49,493
|
46,890
|
96,383
|
|
Nathan Schultz
|
39,975
|
37,874
|
77,849
|
|
Michael Osier
|
39,975
|
37,874
|
77,849
|
|
Esther Lem
|
32,361
|
30,658
|
63,019
|
|
Jenny Brandemuehl
|
32,361
|
30,658
|
63,019
|
|
Position
|
Stock Ownership Requirement
|
|
CEO
|
Three times annual cash salary
|
|
Other Executive Officers
|
One times annual cash salary
|
|
Non-Employee Directors
|
One times annual cash retainer
|
|
Name and Principal Position
(1)
|
Year
|
Salary ($)
|
Stock Awards ($)
(2)
|
All Other
Compensation
($)
(3)
|
Total ($)
|
|
Dan Rosensweig
|
2018
|
986,667
|
8,124,969
|
5,871
|
9,117,507
|
|
President and Chief Executive Officer
|
2017
|
920,000
|
7,124,994
|
—
|
8,044,994
|
|
|
2016
|
905,417
|
5,609,900
|
—
|
6,515,317
|
|
Andrew Brown
|
2018
|
586,667
|
3,249,968
|
6,000
|
3,842,635
|
|
Chief Financial Officer
|
2017
|
520,000
|
2,784,681
|
6,000
|
3,310,681
|
|
|
2016
|
514,792
|
2,152,831
|
6,000
|
2,673,623
|
|
Nathan Schultz
|
2018
|
491,667
|
2,624,985
|
4,625
|
3,121,277
|
|
President of Learning Services
|
2017
|
446,120
|
2,226,553
|
4,500
|
2,677,173
|
|
|
2016
|
419,100
|
1,568,750
|
4,500
|
1,992,350
|
|
Michael Osier
|
2018
|
491,667
|
2,624,985
|
—
|
3,116,652
|
|
Chief Information Officer and Chief Outcomes Officer
|
2017
|
446,120
|
2,226,553
|
—
|
2,672,673
|
|
|
2016
|
419,100
|
1,568,750
|
—
|
1,987,850
|
|
Esther Lem
|
2018
|
398,333
|
2,124,980
|
6,125
|
2,529,438
|
|
Chief Marketing Officer
|
2017
|
390,000
|
1,781,246
|
6,000
|
2,177,246
|
|
|
2016
|
383,207
|
1,255,000
|
—
|
1,638,207
|
|
Jenny Brandemuehl
|
2018
|
398,333
|
2,124,980
|
6,125
|
2,529,438
|
|
Chief People Officer
|
2017
|
383,333
|
1,781,246
|
6,000
|
2,170,579
|
|
|
2016
|
338,333
|
1,999,500
|
6,000
|
2,343,833
|
|
(1)
|
Messrs. Schultz and Osier and Ms. Lem were not NEOs in 2016. Ms. Brandemuehl was not an NEO in 2017 but was an NEO in 2016.
|
|
(2)
|
The amounts reported in this column represent the aggregate grant date fair value of RSU and PSU awards granted under our 2013 Equity Incentive Plan, as computed in accordance with ASC 718. The grant date fair value was determined using the closing share price of our common stock on the date of grant. For fiscal year 2018, the amounts include PSUs, valued at the grant date based upon the probable outcome of the performance conditions. The aggregate grant date fair values of the PSUs in the table above reflect the maximum potential value of the PSUs (assuming the highest level of performance achievement) and were $4,874,982 for Mr. Rosensweig, $1,949,985 for Mr. Brown, $1,574,995 for Mr. Schultz, $1,574,995 for Mr. Osier, $1,274,984 for Ms. Lem, and $1,274,984 for Ms. Brandemuehl.
|
|
(3)
|
Represents our contributions to the account under our 401(k) plan with respect to each of Messrs. Rosensweig, Brown, Schultz and Mss. Lem and Brandemuehl.
|
|
|
|
Grant
Date
|
|
Board
Approval
Date
|
|
Award
Type
|
|
Estimated Possible Payout
Under Equity Incentive
Plan Awards
(1)
|
|
All Other
Stock Awards:
Number of
Shares of Stock or Units (#)
(2)
|
|
Market
Value of
Shares that
Have Not
Vested ($)
(3)
|
||||
|
Name
|
|
|
|
|
Threshold (#)
|
|
Target (#)
|
|
Maximum (#)
|
|||||||
|
Dan Rosensweig
|
|
3/01/2018
|
|
2/9/2018
|
|
PSU
|
|
81,662
|
|
164,974
|
|
247,461
|
|
—
|
|
4,874,982
|
|
|
|
3/01/2018
|
|
12/13/2017
|
|
RSU
|
|
—
|
|
—
|
|
—
|
|
164,974
|
|
3,249,988
|
|
Andrew Brown
|
|
3/01/2018
|
|
2/9/2018
|
|
PSU
|
|
32,664
|
|
65,989
|
|
98,984
|
|
—
|
|
1,949,985
|
|
|
|
3/01/2018
|
|
12/13/2017
|
|
RSU
|
|
—
|
|
—
|
|
—
|
|
65,989
|
|
1,299,983
|
|
Nathan Schultz
|
|
3/01/2018
|
|
2/9/2018
|
|
PSU
|
|
26,383
|
|
53,299
|
|
79,949
|
|
—
|
|
1,574,995
|
|
|
|
3/01/2018
|
|
12/13/2017
|
|
RSU
|
|
—
|
|
—
|
|
—
|
|
53,299
|
|
1,049,990
|
|
Michael Osier
|
|
3/01/2018
|
|
2/9/2018
|
|
PSU
|
|
26,383
|
|
53,299
|
|
79,949
|
|
—
|
|
1,574,995
|
|
|
|
3/01/2018
|
|
12/13/2018
|
|
RSU
|
|
—
|
|
—
|
|
—
|
|
53,299
|
|
1,049,999
|
|
Esther Lem
|
|
3/01/2018
|
|
2/9/2018
|
|
PSU
|
|
21,357
|
|
43,147
|
|
64,720
|
|
—
|
|
1,274,984
|
|
|
|
3/01/2018
|
|
12/13/2017
|
|
RSU
|
|
—
|
|
—
|
|
—
|
|
43,147
|
|
849,996
|
|
Jenny Brandemuehl
|
|
3/01/2018
|
|
2/9/2018
|
|
PSU
|
|
21,357
|
|
43,147
|
|
64,720
|
|
—
|
|
1,274,984
|
|
|
|
3/01/2018
|
|
12/13/2017
|
|
RSU
|
|
—
|
|
—
|
|
—
|
|
43,147
|
|
849,996
|
|
(1)
|
Upon the achievement by December 31, 2018 of certain company performance metric measurements approved by the compensation committee as described under the heading “-Elements of Fiscal Year Compensation-Equity Incentive Compensation-Performance-Based Restricted Stock Units,” the RSUs earned (if any) with respect to each performance metric vested as to one-third on March 1, 2019, and shall vest as to one-third on the one year anniversary of the initial determined vesting date, and the remaining one-third shall vest on the two-year anniversary of the initial determined vesting date, subject in each case to the applicable officer’s continued service up to and through the applicable vesting dates.
|
|
(2)
|
One-third of the shares shall vest, or have vested, annually on each anniversary of the vesting commencement date of March 1, 2018 (e.g., March 1, 2019, March 1, 2020, and March 1, 2021). The vesting is subject to continued service through each vesting date.
|
|
(3)
|
Reflects the grant date fair value of each equity award at the maximum performance level computed in accordance with ASC Topic 718 and described in footnote 2 to the Summary Compensation Table. The assumptions used in the valuation of these awards are set forth in the notes to our consolidated financial statements included in our Annual Report on Form 10-K filed with the SEC for the year ended December 31, 2018. These amounts may not correspond to the actual value that may be realized by the NEOs.
|
|
|
|
|
|
Option Awards
|
|
Stock Awards
|
||||||||
|
|
|
Grant
Date
(1)
|
|
Number of Securities
Underlying Unexercised
Options
|
|
Exercise
Price ($)
|
|
Expiration
Date
|
|
Number of
Shares that
Have Not
Vested (#)
|
|
Market
Value of
Shares that
Have Not
Vested ($)
(2)
|
||
|
Name
|
|
|
Exercisable (#)
|
|
Unexercisable (#)
|
|
||||||||
|
Dan Rosensweig
|
|
3/17/2011
(3)
|
|
68,251
|
|
—
|
|
7.88
|
|
2/3/2020
|
|
|
|
|
|
|
|
11/7/2012
|
|
717,596
|
|
—
|
|
6.92
|
|
11/6/2022
|
|
|
|
|
|
|
|
11/12/2013
|
|
314,407
|
|
—
|
|
12.50
|
|
11/11/2023
|
|
|
|
|
|
|
|
11/12/2013
|
|
666,666
|
|
—
|
|
12.50
|
|
11/11/2023
|
|
|
|
|
|
|
|
2/23/2016
(4)
|
|
|
|
|
|
|
|
|
|
250,000
|
|
7,105,000
|
|
|
|
3/14/2016
(5)
|
|
|
|
|
|
|
|
|
|
375,000
|
|
10,657,500
|
|
|
|
3/1/2017
(6)
|
|
|
|
|
|
|
|
|
|
232,844
|
|
6,617,426
|
|
|
|
3/1/2017
(7)
|
|
|
|
|
|
|
|
|
|
349,265
|
|
9,926,111
|
|
|
|
3/1/2018
(8)
|
|
|
|
|
|
|
|
|
|
164,974
|
|
4,688,561
|
|
|
|
3/1/2018
(9)
|
|
|
|
|
|
|
|
|
|
247,461
|
|
7,032,842
|
|
Andrew Brown
|
|
11/2/2011
|
|
202,318
|
|
—
|
|
7.88
|
|
11/1/2021
|
|
|
|
|
|
|
|
11/12/2013
|
|
77,088
|
|
—
|
|
12.50
|
|
11/11/2023
|
|
|
|
|
|
|
|
11/12/2013
|
|
266,666
|
|
—
|
|
12.50
|
|
11/11/2023
|
|
|
|
|
|
|
|
2/23/2016
(10)
|
|
|
|
|
|
|
|
|
|
97,708
|
|
2,776,861
|
|
|
|
3/14/2016
(5)
|
|
|
|
|
|
|
|
|
|
146,563
|
|
4,165,320
|
|
|
|
3/1/2017
(6)
|
|
|
|
|
|
|
|
|
|
91,004
|
|
2,586,334
|
|
|
|
3/1/2017
(7)
|
|
|
|
|
|
|
|
|
|
136,504
|
|
3,879,444
|
|
|
|
3/1/2018
(8)
|
|
|
|
|
|
|
|
|
|
65,989
|
|
1,875,407
|
|
|
|
3/1/2018
(9)
|
|
|
|
|
|
|
|
|
|
98,984
|
|
2,813,125
|
|
Nathan Schultz
|
|
5/16/2012
|
|
100,000
|
|
—
|
|
7.88
|
|
5/15/2022
|
|
|
|
|
|
|
|
11/12/2013
|
|
47,376
|
|
—
|
|
12.50
|
|
11/11/2023
|
|
|
|
|
|
|
|
11/12/2013
|
|
200,000
|
|
—
|
|
12.50
|
|
11/11/2023
|
|
|
|
|
|
|
|
2/23/2016
(11)
|
|
|
|
|
|
|
|
|
|
78,125
|
|
2,220,313
|
|
|
|
3/14/2016
(5)
|
|
|
|
|
|
|
|
|
|
117,188
|
|
3,330,483
|
|
|
|
3/1/2017
(12)
|
|
|
|
|
|
|
|
|
|
72,764
|
|
2,067,953
|
|
|
|
3/1/2017
(7)
|
|
|
|
|
|
|
|
|
|
109,145
|
|
3,101,901
|
|
|
|
3/1/2018
(13)
|
|
|
|
|
|
|
|
|
|
53,299
|
|
1,514,758
|
|
|
|
3/1/2018
(9)
|
|
|
|
|
|
|
|
|
|
79,949
|
|
2,272,151
|
|
Michael Osier
|
|
2/23/2016
(11)
|
|
|
|
|
|
|
|
|
|
78,125
|
|
2,220,313
|
|
|
|
3/14/2016
(5)
|
|
|
|
|
|
|
|
|
|
117,188
|
|
3,330,483
|
|
|
|
3/1/2017
(12)
|
|
|
|
|
|
|
|
|
|
72,764
|
|
2,067,953
|
|
|
|
3/1/2017
(7)
|
|
|
|
|
|
|
|
|
|
109,145
|
|
3,101,901
|
|
|
|
3/1/2018
(13)
|
|
|
|
|
|
|
|
|
|
53,299
|
|
1,514,758
|
|
|
|
3/1/2018
(9)
|
|
|
|
|
|
|
|
|
|
79,949
|
|
2,272,151
|
|
Esther Lem
|
|
2/9/2011
|
|
150,000
|
|
—
|
|
7.88
|
|
2/8/2021
|
|
|
|
|
|
|
|
11/7/2012
|
|
53,333
|
|
—
|
|
6.92
|
|
11/6/2022
|
|
|
|
|
|
|
|
11/12/2013
|
|
29,309
|
|
—
|
|
12.50
|
|
11/11/2023
|
|
|
|
|
|
|
|
11/12/2013
|
|
133,333
|
|
—
|
|
12.50
|
|
11/11/2023
|
|
|
|
|
|
|
|
2/23/2016
(11)
|
|
|
|
|
|
|
|
|
|
62,500
|
|
1,776,250
|
|
|
|
3/14/2016
(5)
|
|
|
|
|
|
|
|
|
|
93,750
|
|
2,664,375
|
|
|
|
3/1/2017
(12)
|
|
|
|
|
|
|
|
|
|
58,211
|
|
1,654,357
|
|
|
|
3/1/2017
(7)
|
|
|
|
|
|
|
|
|
|
87,316
|
|
2,481,521
|
|
|
|
3/1/2018
(13)
|
|
|
|
|
|
|
|
|
|
43,147
|
|
1,226,238
|
|
|
|
3/1/2018
(9)
|
|
|
|
|
|
|
|
|
|
64,720
|
|
1,839,342
|
|
Jenny Brandemuehl
|
|
2/28/2013
|
|
107,583
|
|
—
|
|
7.64
|
|
2/27/2023
|
|
|
|
|
|
|
|
3/1/2016
(14)
|
|
|
|
|
|
|
|
|
|
25,000
|
|
710,500
|
|
|
|
8/1/2016
(15)
|
|
|
|
|
|
|
|
|
|
100,000
|
|
2,842,000
|
|
|
|
3/1/2017
(12)
|
|
|
|
|
|
|
|
|
|
58,211
|
|
1,654,357
|
|
|
|
3/1/2017
(7)
|
|
|
|
|
|
|
|
|
|
87,316
|
|
2,481,521
|
|
|
|
3/1/2018
(13)
|
|
|
|
|
|
|
|
|
|
43,147
|
|
1,226,238
|
|
|
|
3/1/2018
(9)
|
|
|
|
|
|
|
|
|
|
64,720
|
|
1,839,342
|
|
(1)
|
All of the outstanding equity awards granted prior to November 12, 2013 were granted under our 2005 Stock Incentive Plan. All of the outstanding equity awards granted on or after November 12, 2013 were granted under our 2013 Equity Incentive Plan.
|
|
(2)
|
The market price for our common stock is based on the closing price per share of our common stock as listed on the New York Stock Exchange on December 31, 2018 of $28.42.
|
|
(3)
|
Includes 68,251 shares subject to stock options transferred as a gift to Daniel Lee Rosensweig and Linda Rosensweig Co-Trustees of the Rosensweig 2012 Irrevocable Children’s Trust u/a/d 11/6/2012 on November 8, 2013.
|
|
(4)
|
The award of RSUs vested with respect to 170,000 RSUs on October 1, 2016, 50% of the remaining RSUs vested on February 23, 2018, and the remaining 50% of the awarded RSUs vested on February 23, 2019.
|
|
(5)
|
The shares subject to the PSU award were earned only upon achievement by December 31, 2016 of company performance metrics consisting of Chegg Services Revenue and adjusted EBITDA as approved by the Compensation Committee. The Compensation Committee determined that the weighted average percentage of 54.8% of the measurements had been achieved, therefore a weighted average of 54.8% of the shares subject to the PSU award were allocable. 50% of the allocated shares vested on March 15, 2018 and the remaining 50% of the allocated shares vested on March 15, 2019.
|
|
(6)
|
One-third of the shares vested, or shall vest, annually on each anniversary of the vesting commencement date, with vesting dates on March 1, 2018, March 1, 2019 and the remaining vested date scheduled for March 1, 2020. The vesting is subject to continued service through each vesting date and acceleration as described in “—Termination and Change of Control Arrangements” below.
|
|
(7)
|
The shares subject to the PSU award were earned only upon achievement by December 31, 2017 of company performance metrics consisting of Chegg Services Revenue and adjusted EBITDA as approved by the Compensation Committee. The Compensation Committee determined that the weighted average percentage of 100% (i.e., 150% of Target) of the measurements had been achieved, therefore a weighted average of 100% (i.e., 150% of Target) of the shares subject to the PSU award were allocable. 1/3rd of the allocated shares vested on March 1, 2018, 1/3rd of the allocated shares vested on March 1, 2019, and the remaining 1/3rd of the allocated shares are scheduled to vest on March 1, 2020, subject to the officer's continued service up to and through the vesting date.
|
|
(8)
|
One-third of the shares vested, or shall vest, annually on each anniversary of the vesting commencement date, with a vesting date on March 1, 2019 and the remaining vested dates scheduled for March 1, 2020 and March 1, 2021. The vesting is subject to continued service through each vesting date and acceleration as described in “—Termination and Change of Control Arrangements” below.
|
|
(9)
|
The shares subject to the PSU award were earned only upon achievement by December 31, 2018 of company performance metrics consisting of Chegg Services Revenue and adjusted EBITDA as approved by the Compensation Committee. The Compensation Committee determined that the weighted average percentage of 97.4% (i.e., 146.1% of Target) of the measurements had been achieved, therefore a weighted average of 97.4% (i.e., 146.1% of Target) of the shares subject to the PSU award were allocable. 1/3rd of the allocated shares vested on March 1, 2019, 1/3rd of the allocated shares are scheduled to vest on March 1, 2020, and the remaining 1/3rd of the allocated shares are scheduled to vest on March 1, 2021, subject in each case to the officer's continued service up to and through the applicable vesting date.
|
|
(10)
|
The award of RSUs vested in respect to 55,000 RSUs on October 1, 2016, 50% of the remaining RSUs vested on February 23, 2018, and the remaining RSUs vested on February 23, 2019.
|
|
(11)
|
The award of RSUs vested with respect to 50% of the shares on February 23, 2018 and the remaining 50% of the shares on February 23, 2019.
|
|
(12)
|
One-third of the shares vested, or shall vest, annually on each anniversary of the vesting commencement date, with vesting dates of March 1, 2018 and March 1, 2019 and the remaining vesting date scheduled for March 1, 2020. The vesting is subject to continued service through each vesting date.
|
|
(13)
|
One-third of the shares vested, or shall vest, annually on each anniversary of the vesting commencement date, with a vesting date of March 1, 2019 and the remaining vesting dates scheduled for March 1, 2020 and March 1, 2021. The vesting is subject to continued service through each vesting date.
|
|
(14)
|
One-third of the shares vested annually on each anniversary of the vesting commencement date, with vesting dates on March 1, 2017, March 1, 2018 and March 1, 2019.
|
|
(15)
|
One-third of the shares vested annually on each anniversary of the vesting commencement date, with vesting dates on August 12, 2017, August 12, 2018 and August 12, 2019.
|
|
|
Option Awards
|
|
Stock Awards
|
|||||
|
|
|
Number of Shares Acquired on Exercise
|
|
Value Realized on Exercise
($)
(1)
|
|
Number of Shares
Acquired on Vesting
(2)
|
|
Value
Realized
on Vesting
($)
(3)
|
|
Name
|
|
|||||||
|
Dan Rosensweig
|
|
1,265,082
|
|
24,515,462
|
|
746,664
|
|
15,291,229
|
|
Andrew Brown
|
|
278,952
|
|
5,182,080
|
|
291,819
|
|
5,976,277
|
|
Nathan Schultz
|
|
66,666
|
|
903,658
|
|
233,331
|
|
4,778,478
|
|
Michael Osier
|
|
353,813
|
|
4,013,276
|
|
233,331
|
|
4,778,478
|
|
Esther Lem
|
|
—
|
|
—
|
|
186,665
|
|
3,822,786
|
|
Jenny Brandemuehl
|
|
92,417
|
|
1,746,014
|
|
197,763
|
|
4,876,931
|
|
(1)
|
The value realized on the shares acquired is the fair market value of the shares on the date of exercise, which was the closing price of our common stock on such date as traded on the New York Stock Exchange (“NYSE”), less the exercise price for the stock option award.
|
|
(2)
|
Amounts reflect the vesting of RSUs and PSUs.
|
|
(3)
|
The value realized on the shares acquired is the fair market value of the shares on the date of vesting, which was the closing price of our common stock on such date as traded on the NYSE.
|
|
|
|
Termination of Employment
No Change of Control
|
|
Termination of Employment
Change of Control
|
||||||
|
Named Executive Officer
|
|
Severance Payment ($)
|
Medical Benefits Continuation ($)
(1)
|
Accelerated Vesting of Equity Awards ($)
(2)
|
Total ($)
|
|
Severance Payment ($)
|
Medical Benefits Continuation ($)
(1)
|
Accelerated Vesting of Equity Awards ($)
(2)
|
Total ($)
|
|
Dan Rosensweig
|
|
1,000,000
|
31,229
|
4,602,747
|
5,633,976
|
|
1,000,000
|
31,229
|
18,410,988
|
19,442,217
|
|
Andrew Brown
|
|
600,000
|
18,863
|
3,619,301
|
4,238,164
|
|
600,000
|
18,863
|
3,619,301
|
4,238,164
|
|
Nathan Schultz
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
Michael Osier
|
|
250,000
|
—
|
—
|
250,000
|
|
250,000
|
—
|
—
|
250,000
|
|
Esther Lem
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
Jenny Brandemuehl
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
(1)
|
The amounts reported represent costs for COBRA.
|
|
(2)
|
The value of the accelerated vesting of unvested equity awards has been calculated based on the closing market price of our common stock on the NYSE on December 31, 2018, which was $28.42 per share. All outstanding stock options are fully vested and not included in the total.
|
|
Plan category
|
|
Number of securities to be
issued upon exercise
of outstanding options,
warrants and rights
|
|
Weighted-average exercise price of
outstanding options,
warrants and rights
|
|
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a))
|
|
|
|
(a)
|
|
(b)
|
|
(c)
|
|
Equity compensation plans approved by security holders
|
|
15,578,303
(1)
|
|
$9.40
(2)
|
|
23,648,778
(3)
|
|
Equity compensation plans not approved by security holders
(4)
|
|
—
|
|
—
|
|
—
|
|
(1)
|
Excludes purchase rights accruing under the 2013 ESPP and includes 10,804,808 shares subject to outstanding RSUs.
|
|
(2)
|
The weighted average exercise price relates solely to outstanding stock option shares since shares subject to RSUs have no exercise price.
|
|
(3)
|
Consists of 16,955,417 shares available for issuance under the 2013 Plan and 6,693,361 shares available for issuance under the 2013 ESPP.
The number of shares reserved for issuance under the 2013 Plan will increase automatically on the first day of January of each of the first ten calendar years during the term of the plan by a number of shares of common stock equal to the lesser of (i) 5% of the total outstanding shares our common stock as of the immediately preceding December 31st or (ii) a number of shares determined by our board of directors.
The number of shares reserved for issuance under our 2013 ESPP will increase automatically on January 1st of each of the first ten calendar years following the first offering date by the number of shares equal to the lesser of (i) 1% of the total outstanding shares of our common stock as of the immediately preceding December 31st (rounded to the nearest whole share) or (ii) a number of shares determined by our board of directors.
Pursuant to the terms of our 2013 Plan and 2013 ESPP, an additional 5,775,020 shares and 1,155,004 shares were added to the number of shares reserved for issuance under each plan, respectively, effective January 1, 2019.
|
|
(4)
|
Excludes information for options and other equity awards assumed by us in connection with mergers and acquisitions and warrants issued by us in connection with financing transactions. As of December 31, 2018, a total of 2,986 shares of our common stock were issuable upon exercise of outstanding options assumed. The weighted average exercise price of those outstanding options was $3.79 per share. No additional equity awards may be granted under any equity compensation plans or arrangements assumed by us in connection with mergers and acquisitions.
|
|
•
|
we have been or are to be a participant;
|
|
•
|
the amount involved exceeded or exceeds $120,000; and
|
|
•
|
any of our directors, executive officers or holders of more than 5% of our capital stock, or any immediate family member of or person sharing the household with any of these individuals, had or will have a direct or indirect material interest.
|
|
|
Years Ended
December 31, |
||
|
|
2018
|
||
|
Net income (loss)
|
$
|
(14,888
|
)
|
|
Interest expense, net
|
11,225
|
|
|
|
(Benefit from) provision for income taxes
|
1,430
|
|
|
|
Depreciation and amortization expense
|
22,805
|
|
|
|
EBITDA
|
20,572
|
|
|
|
Share-based compensation expense
|
52,030
|
|
|
|
Other income, net
|
(3,987
|
)
|
|
|
Restructuring charges
|
589
|
|
|
|
Acquisition-related compensation costs
|
14,096
|
|
|
|
Adjusted EBITDA
|
$
|
83,300
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|